These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6742902)

  • 1. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
    Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W
    Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive systemic sclerosis complicated with immune thrombocytopenia during D-penicillamine therapy.
    Natsuda H; Matsui Y; Sakauchi M; Kato S; Takemura H; Suzuki H; Kono I; Yamane K; Kashiwagi H
    Intern Med; 1992 Feb; 31(2):244-5. PubMed ID: 1600273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelotoxicity of D-penicillamine.
    Kay AG
    Ann Rheum Dis; 1979 Jun; 38(3):232-6. PubMed ID: 485580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.
    Weiss AS; Markenson JA; Weiss MS; Kammerer WH
    Am J Med; 1978 Jan; 64(1):114-20. PubMed ID: 623127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity to D-penicillamine in rheumatoid arthritis.
    Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK
    Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatment.
    Kang SS; Wong PW; Glickman PB; MacLeod CM; Jaffe IA
    J Clin Pharmacol; 1986; 26(8):712-5. PubMed ID: 3793964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
    Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 15. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)].
    Franck JL; Bouteiller G; Gayrard M; Arlet J
    Sem Hop; 1979 Sep 8-15; 55(27-30):1325-7. PubMed ID: 228408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.
    Tishler M; Kahn Y; Yaron M
    Ann Rheum Dis; 1991 Apr; 50(4):255-6. PubMed ID: 1903031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [To be noted in D-penicillamine therapy].
    Blut; 1974 May; 28(5):374-5. PubMed ID: 4418117
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
    Rosenbaum J; Katz WA; Schumacher HR
    Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.